top of page
NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
43598-0563-25 | J2501 | INJECTION, PARICALCITOL, 1 MCG | PARICALCITOL (SDV) 0.002 MG/1 ML | IV |
43598-0564-25 | J2501 | INJECTION, PARICALCITOL, 1 MCG | PARICALCITOL (SDV) 0.005 MG/1 ML | IV |
43598-0565-10 | J2501 | INJECTION, PARICALCITOL, 1 MCG | PARICALCITOL (MDV) 0.005 MG/1 ML | IV |
43598-0605-56 | J7682 | TOBRAMYCIN, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, UNIT DOSE FORM, ADMINISTERED THROUGH DME, PER 300 MILLIGRAMS | TOBRAMYCIN (4 AMPULES X 14 POUCHES) 300 MG/5 ML | IH |
49452-4800-01 | J2300 | INJECTION, NALBUPHINE HYDROCHLORIDE, PER 10 MG | NALBUPHINE HCL | NA |
49452-4800-02 | J2300 | INJECTION, NALBUPHINE HYDROCHLORIDE, PER 10 MG | NALBUPHINE HCL | NA |
49452-4800-03 | J2300 | INJECTION, NALBUPHINE HYDROCHLORIDE, PER 10 MG | NALBUPHINE HCL | NA |
49452-4836-02 | J2310 | INJECTION, NALOXONE HYDROCHLORIDE, PER 1 MG | NALOXONE HCL DIHYDRATE (U.S.P.) | NA |
49452-4836-03 | J2310 | INJECTION, NALOXONE HYDROCHLORIDE, PER 1 MG | NALOXONE HCL DIHYDRATE (U.S.P.) | NA |
49452-4836-04 | J2310 | INJECTION, NALOXONE HYDROCHLORIDE, PER 1 MG | NALOXONE HCL DIHYDRATE (U.S.P.) | NA |
49452-4936-01 | J2360 | INJECTION, ORPHENADRINE CITRATE, UP TO 60 MG | ORPHENADRINE CITRATE (U.S.P.) | NA |
49452-4936-02 | J2360 | INJECTION, ORPHENADRINE CITRATE, UP TO 60 MG | ORPHENADRINE CITRATE (U.S.P.) | NA |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page